Diabetes Alert Day: Treatment and Prevention

What is Diabetes Alert Day? Since 1987, the American Diabetes Association has named the 4th Tuesday in March as Diabetes Alert Day. This year it falls on March 28th. Diabetes Alert Day was created as a public “wake-up call” to the seriousness of diabetes and the importance of understanding the associated risks of living with […]
What are the side effects of semaglutide in Ozempic and Wegovy?

Semaglutide is one of the ‘wonder drugs’ that revolutionized the treatment of adults suffering from type 2 diabetes and then went on to become a popular option for patients looking to lose weight. Like all drugs, there can be risk factors that result in side effects of semaglutide. Semaglutide belongs to a class of drugs […]
News coming out of November’s ObesityWeek

The opening week of November saw a flood of news at ObesityWeek regarding progress that has been made in the fight against obesity. Some of the discussions concerned social and economic changes that the gathering of specialists in this area is calling for, and many more items dealt with progress that has been made, and […]
Introducing the new once-a-day pill for Type 2 diabetes that replaces weekly injections
In 2017, a new drug came onto the market that radically improved therapy for adult sufferers of Type 2 diabetes. That new treatment is a once-a-week self-injectable dose of Ozempic, and it contains a newly developed drug called semaglutide. Now, the drug company Novartis that developed Ozempic has released a pill-form of semaglutide that can […]
Do you qualify for use of the latest weight-loss wonder Ozempic?
Visit our Ozempic website page to find out if you now qualify to receive this remarkable new treatment that promotes weight loss. There has been a tremendous revolution in the approach that you can now take to help fight obesity. It started when the use of a weekly injectable drug for type II diabetics called […]
Negotiating the maze of weight-loss drugs
A recent article on yahoo!news painted a highly complicated picture of how patients and doctors in the U.S. are trying to negotiate their way through the new field of advanced drugs that promote weight loss. The article quotes an obesity medicine specialist at Massachusetts General Hospital and Harvard Medical School, saying “Access to medicines for […]